- USA
- Seed
- Biotech
- Health & Hospital Services
- Digital Health
- Health It
- -
BioVerge is a platform enabling investment in healthcare startups. They leverage deep domain expertise and proprietary deal access to drive compelling riskadjusted returns.
Investment Thesis
Team
Executive Team:
Neil J. Littman: Founder
Chief Executive Officer
Managing Director
Rick Gibb: Founder
Chief Operating Officer
Managing Director
Advisors:
Sonia Arrison: Venture Partner
Portfolia; Founder
100 Plus Capital; Board Chair
The Alliance for Longevity Initiatives
Brenden Boot
M.D.: Neurologist
Brigham and Women's Hospital; Assistant Professor
Harvard Medical School
Mark Chao
Ph.D.: Cofounder and CEO
TenSixteen
Dave Chisholm: Partner Manager
Dassault Systèmes
Kevin Coker
JD
MPH
MS: Cofounder & CEO
Proxima Clinical Research
Curt Herberts: President & COO
Kriya Therapeutics
Brock Reeve
Ph.D.: Cofounder & CEO
Eos BioInnovation; Executive Director
Harvard Stem Cell Institute
Greg Simon: Biden Cancer Initiative; Executive Director
White House Cancer Moonshot Task Force
David Stubbs: Head of European Health Care
Raymond James Financial International
Ltd.
Joseph Wu
M.D. Ph.D.: Professor & Director
Stanford Cardiovascular Institute; PresidentElect
American Heart Association; Cofounder
Greenstone Biosciences
Portfolio
Ancilla
Alto Neuroscience
Aspen Neuroscience
Bionaut Labs
Biobot Analytics
BioRosa Technologies
BioIntelliSense
Circularis
CrowdMed
ContraLine
ECHO Labs
EnClear Therapies
Excision BioTherapeutics
Elucid Bioimaging
Enveda Biosciences
Eigen Therapeutics
Foresight Diagnostics
GigaMune
HepaTx
Intelligent Implants
IVIVA Medical
Juno Bio
JelikaLite
Leucadia Therapeutics
LISCure Biosciences
Modulo
Notable Labs
NutriSense
Octagon Therapeutics
Octant
Ombre
Ochre Bio
Pragma Therapeutics
Repair Biotechnologies
RockStep Solutions
Suggestic
Vaxess Technologies